Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$738
|
$698B |
13.7x |
34.8x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$186
|
$393B |
6.8x |
15.1x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$155
|
$387B |
4.3x |
11.9x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$77
|
$219B |
3.4x |
8.0x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$288
|
$204B |
6.0x |
10.6x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$403
|
$180B |
4.2x |
16.6x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$23
|
$178B |
2.8x |
7.3x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$110
|
$154B |
5.4x |
12.5x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$190
|
$150B |
6.2x |
19.8x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$48
|
$138B |
2.9x |
12.1x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$442
|
$109B |
9.6x |
39.7x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$169
|
$80.1B |
8.6x |
20.0x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$490
|
$47.3B |
3.4x |
9.3x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$513
|
$42.2B |
10.6x |
31.2x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$305
|
$38.4B |
15.3x |
232.0x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$140
|
$36.9B |
2.4x |
9.9x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$112
|
$33.8B |
5.1x |
17.4x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$249
|
$27.0B |
2.0x |
11.9x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1156
|
$26.0B |
6.7x |
20.9x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$173
|
$25.7B |
2.5x |
12.7x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$23.8B |
1.7x |
5.4x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$325
|
$23.3B |
10.3x |
46.4x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$130
|
$23.0B |
2.4x |
7.1x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$349
|
$21.9B |
7.3x |
20.0x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$158
|
$20.7B |
11.4x |
-85.5x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$33
|
$19.7B |
6.8x |
7.4x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$82
|
$14.4B |
3.3x |
12.5x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$130
|
$13.4B |
1.6x |
8.0x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$13.2B |
N/A |
-50.5x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$90
|
$12.8B |
4.6x |
14.9x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$12.6B |
31.1x |
-13.9x |
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$56
|
$12.4B |
4.3x |
33.3x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$123
|
$11.7B |
4.7x |
18.6x |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$877
|
$11.4B |
N/A |
N/A |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$318
|
$11.2B |
3.7x |
7.0x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$10.9B |
4.9x |
14.7x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.8B |
1.7x |
5.5x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$13
|
$10.6B |
2.4x |
12.0x |
Biomarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$58
|
$10.5B |
3.5x |
14.3x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$65
|
$10.2B |
2.3x |
18.3x |
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$45
|
$10.2B |
5.1x |
13.8x |
Ingredion
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$139
|
$9.9B |
1.3x |
8.0x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$108
|
$9.5B |
2.3x |
6.6x |
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$136
|
$9.4B |
2.4x |
9.7x |
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$295
|
$8.2B |
3.8x |
17.1x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$77
|
$7.9B |
10.3x |
N/A |
Bio-Techne
|
United States of America |
Laboratory Services,
Pharma Diagnostics & Analytics
|
$48
|
$7.9B |
6.5x |
18.8x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$34
|
$7.8B |
26.7x |
-15.4x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$56
|
$7.7B |
6.9x |
10.8x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$96
|
$7.5B |
2.8x |
-5.5x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$27
|
$6.9B |
1.6x |
9.2x |
Repligen
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$118
|
$6.6B |
9.9x |
52.6x |
Blueprint Medicines
|
United States of America |
Drug Development & Therapeutics
|
$101
|
$6.4B |
10.8x |
-52.3x |
Stevanato Group
|
United States of America |
Medical Supplies,
Drug Delivery Systems
|
$22
|
$6.4B |
5.1x |
21.2x |
Guardant Health
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$41
|
$5.6B |
7.1x |
-23.2x |
Sotera Health
|
United States of America |
Laboratory Services,
Medical Supplies
|
$12
|
$5.5B |
4.9x |
9.9x |
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$5.4B |
12.6x |
54.7x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$275
|
$5.4B |
14.1x |
-12.0x |
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$39
|
$5.4B |
2274.2x |
-6.7x |
RadNet
|
United States of America |
Medical Imaging & Diagnostics,
Laboratory Services
|
$58
|
$5.3B |
2.8x |
18.9x |
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$86
|
$5.2B |
4.5x |
13.8x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$105
|
$5.1B |
10.6x |
-27.4x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$27
|
$5.0B |
1.8x |
-1.3x |
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$76
|
$4.9B |
3.2x |
7.2x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$4.8B |
1.7x |
7.5x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$20
|
$4.7B |
10.3x |
24.4x |
Nomad Foods
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$17
|
$4.7B |
1.4x |
7.7x |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$29
|
$4.7B |
5.9x |
-28.0x |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$4.6B |
8.3x |
29.5x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$34
|
$4.6B |
6.4x |
-10.1x |
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$4.5B |
2.1x |
14.6x |
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$75
|
$4.3B |
N/A |
-14.0x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$31
|
$4.2B |
2.9x |
10.8x |
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$61
|
$3.7B |
25.1x |
-16.4x |
Endo
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$21
|
$3.7B |
N/A |
N/A |
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$3.6B |
N/A |
N/A |
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$3.6B |
174.3x |
-6.1x |
Soleno Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$73
|
$3.5B |
178.2x |
N/A |
Merus
|
United States of America |
Drug Development & Therapeutics
|
$56
|
$3.4B |
75.2x |
-12.1x |
Akero Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$50
|
$3.3B |
N/A |
-10.6x |
SpringWorks Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$47
|
$3.2B |
12.9x |
-13.6x |
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$126
|
$3.0B |
8.9x |
24.0x |
ACADIA Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$3.0B |
3.0x |
17.1x |
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$62
|
$2.9B |
32.1x |
-16.6x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$2.8B |
57.5x |
N/A |
Ultragenyx
|
United States of America |
Drug Development & Therapeutics
|
$34
|
$2.8B |
4.6x |
-6.1x |
BioCryst Pharma
|
United States of America |
Drug Development & Therapeutics
|
$11
|
$2.7B |
5.3x |
72.0x |
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$11
|
$2.7B |
94.8x |
-2.6x |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$33
|
$2.6B |
N/A |
N/A |
Catalyst Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$25
|
$2.5B |
4.8x |
10.3x |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$29
|
$2.5B |
836.6x |
-9.6x |
BGM Group
|
United States of America |
Drug Development & Therapeutics
|
$13
|
$2.4B |
N/A |
N/A |
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$47
|
$2.4B |
8.3x |
23.8x |
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$2.4B |
262.5x |
-5.4x |
Lyell Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$2.3B |
49755.5x |
-9.0x |
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$26
|
$2.3B |
20.7x |
-31.3x |
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$44
|
$2.2B |
5.9x |
-42.4x |
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$17
|
$2.2B |
2.9x |
-13.6x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$27
|
$2.2B |
N/A |
N/A |
PTC Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$49
|
$2.2B |
1.8x |
9.1x |